Normalization of glucose homeostasis by a long-acting somatostatin analog SMS 201-995 in a newborn with nesidioblastosis. 1986

G J Bruining, and A N Bosschaart, and R S Aarsen, and S W Lamberts, and P J Sauer, and E Del Pozo

A female child was admitted to the hospital few days after birth with severe hypoglycemia and convulsive episodes. Plasma insulin levels were elevated and oral and intravenous administration of glucose were unable to keep blood glucose above 2 mmol/l limit. Intravenous infusion of a long acting somatostatin analog, SMS 201-995, at a dosage gradually increasing from 2 to 50 micrograms/24 hr, was accompanied by a dramatic fall in circulating insulin levels. Normality of glucose homeostasis was restored and convulsive spells ceased. Fasting blood glucose levels stabilized between 3.4 and 4.7 mmol/l. No rebound phenomenon was observed during short term interruptions of the SMS 201-995 infusion. A subtotal pancreatectomy was performed during SMS treatment, and the diagnosis of nesidioblastosis was confirmed by immunocytologic and electron-microscopic studies. It is concluded that this new potent and long acting somatostatin derivative may be useful in the management of hyperinsulinism in the neonate.

UI MeSH Term Description Entries
D007003 Hypoglycemia A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH. Fasting Hypoglycemia,Postabsorptive Hypoglycemia,Postprandial Hypoglycemia,Reactive Hypoglycemia,Hypoglycemia, Fasting,Hypoglycemia, Postabsorptive,Hypoglycemia, Postprandial,Hypoglycemia, Reactive
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D010180 Pancreatectomy Surgical removal of the pancreas. (Dorland, 28th ed) Pancreatectomies
D010182 Pancreatic Diseases Pathological processes of the PANCREAS. Disease, Pancreatic,Diseases, Pancreatic,Pancreatic Disease
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D005260 Female Females
D006706 Homeostasis The processes whereby the internal environment of an organism tends to remain balanced and stable. Autoregulation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013004 Somatostatin A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal. Cyclic Somatostatin,Somatostatin-14,Somatotropin Release-Inhibiting Hormone,SRIH-14,Somatofalk,Somatostatin, Cyclic,Somatotropin Release-Inhibiting Factor,Stilamin,Somatostatin 14,Somatotropin Release Inhibiting Factor,Somatotropin Release Inhibiting Hormone

Related Publications

G J Bruining, and A N Bosschaart, and R S Aarsen, and S W Lamberts, and P J Sauer, and E Del Pozo
January 1988, The Journal of clinical endocrinology and metabolism,
G J Bruining, and A N Bosschaart, and R S Aarsen, and S W Lamberts, and P J Sauer, and E Del Pozo
September 1990, Journal of endocrinological investigation,
G J Bruining, and A N Bosschaart, and R S Aarsen, and S W Lamberts, and P J Sauer, and E Del Pozo
October 1988, Endocrinologia japonica,
G J Bruining, and A N Bosschaart, and R S Aarsen, and S W Lamberts, and P J Sauer, and E Del Pozo
March 1989, Digestive diseases and sciences,
G J Bruining, and A N Bosschaart, and R S Aarsen, and S W Lamberts, and P J Sauer, and E Del Pozo
December 1989, Scandinavian journal of gastroenterology,
G J Bruining, and A N Bosschaart, and R S Aarsen, and S W Lamberts, and P J Sauer, and E Del Pozo
January 1988, Hormone research,
G J Bruining, and A N Bosschaart, and R S Aarsen, and S W Lamberts, and P J Sauer, and E Del Pozo
March 1988, Zeitschrift fur Gastroenterologie,
G J Bruining, and A N Bosschaart, and R S Aarsen, and S W Lamberts, and P J Sauer, and E Del Pozo
January 1990, The Journal of experimental zoology. Supplement : published under auspices of the American Society of Zoologists and the Division of Comparative Physiology and Biochemistry,
G J Bruining, and A N Bosschaart, and R S Aarsen, and S W Lamberts, and P J Sauer, and E Del Pozo
September 1989, The Journal of clinical endocrinology and metabolism,
G J Bruining, and A N Bosschaart, and R S Aarsen, and S W Lamberts, and P J Sauer, and E Del Pozo
December 1986, Annals of internal medicine,
Copied contents to your clipboard!